Cargando…

Prognosis after resection of single large hepatocellular carcinoma: Results from an Asian high-volume liver surgery center

BACKGROUND & AIMS: In 2012, the Barcelona Clinic Liver Cancer (BCLC) system designated a single large hepatocellular carcinoma (SLHCC) (>5 cm) as BCLC stage A rather than stage B. However, a recent study from western countries reported that prognosis following liver resection (LR) among patie...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Yueh-Wei, Lin, Chih-Che, Yong, Chee-Chien, Wang, Chih-Chi, Chen, Chao-Long, Wang, Jing-Houng, Yen, Yi-Hao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7100934/ https://www.ncbi.nlm.nih.gov/pubmed/32218593 http://dx.doi.org/10.1371/journal.pone.0230897

Ejemplares similares

Alpha-Fetoprotein Combined with Radiographic Tumor Burden Score to Predict Overall Survival after Liver Resection in Hepatocellular Carcinoma
por: Yen, Yi-Hao, et al.
Publicado: (2023)

Adherence to the modified Barcelona Clinic Liver Cancer guidelines: Results from a high-volume liver surgery center in East Asias
por: Yen, Yi-Hao, et al.
Publicado: (2021)

Comparisons of Viral Etiology and Outcomes of Hepatocellular Carcinoma Undergoing Liver Resection between Taiwan and Vietnam
por: Nguyen-Dinh, Song-Huy, et al.
Publicado: (2022)

Liver stiffness and insulin resistance in predicting recurrence for early stage hepatoma patients after curative resection
por: Wang, Jing-Houng, et al.
Publicado: (2021)

Microscopic vascular invasion may not be associated with survival of patients undergoing resection for solitary hepatoma of ≤ 2 cm
por: Li, Wei-Feng, et al.
Publicado: (2023)

Concurrent Cholecystectomy Is Associated with a Lower Risk of Recurrence after Curative Resection in Early-Stage Hepatocellular Carcinoma: A 10 Year Observational Single-Center Study
por: Chen, Yu-Syuan, et al.
Publicado: (2021)

Characteristics and etiologies of hepatocellular carcinoma in patients without cirrhosis: When East meets West
por: Yen, Yi-Hao, et al.
Publicado: (2021)

Real world clinical practice in treating advanced hepatocellular carcinoma: When East meets West
por: Yen, Yi-Hao, et al.
Publicado: (2020)

Resection of an intra-operative ruptured hepatocellular carcinoma with continuous pringle maneuver and in situ hypothermic perfusion through the inferior mesenteric vein - a case report
por: Lin, Yueh-Ming, et al.
Publicado: (2013)

Statin use is associated with a lower risk of recurrence after curative resection in BCLC stage 0-A hepatocellular carcinoma
por: Yang, Shih-Yu, et al.
Publicado: (2021)

Efficacy and Safety of Lenvatinib in Hepatocellular Carcinoma Patients with Liver Transplantation: A Case-Control Study
por: Chen, Yen-Yang, et al.
Publicado: (2021)

Low-dose nivolumab in advanced hepatocellular carcinoma
por: Chen, Yen-Hao, et al.
Publicado: (2022)

Tumor necrosis as a predictor of early tumor recurrence after resection in patients with hepatoma
por: Yen, Yi-Hao, et al.
Publicado: (2023)

The Impact of Direct-Acting Antiviral Therapy on the Risk of Recurrence after Curative Resection in Patients with Hepatitis-C-Virus-Related Early Stage Hepatocellular Carcinoma
por: Chen, Yu-Syuan, et al.
Publicado: (2022)

Real-world comparison of pembrolizumab and nivolumab in advanced hepatocellular carcinoma
por: Chen, Yen-Hao, et al.
Publicado: (2023)

Predictive Effects of Inflammatory Scores in Patients with BCLC 0-A Hepatocellular Carcinoma after Hepatectomy
por: Huang, Pao-Yuan, et al.
Publicado: (2019)

Ability of the post-operative ALBI grade to predict the outcomes of hepatocellular carcinoma after curative surgery
por: Cho, Wei-Ru, et al.
Publicado: (2020)

Impact of MAFLD on HBV-Related Stage 0/A Hepatocellular Carcinoma after Curative Resection
por: Lin, Yen-Po, et al.
Publicado: (2021)

Value of Non-tumoral Liver Volume in the Prognosis of Large Hepatocellular Carcinoma Patients After R0 Resection
por: Zuo, Dongliang, et al.
Publicado: (2023)

Living donor liver transplantation for Barcelona clinic liver cancer (BCLC) intermediate-stage hepatocellular carcinoma
por: Tsai, Ming Chao, et al.
Publicado: (2022)

Characteristics of Psychosocial Factors in Liver Transplantation Candidates with Alcoholic Liver Disease before Transplantation: A Retrospective Study in a Single Center in Taiwan
por: Chen, Yu-Ming, et al.
Publicado: (2020)

Impact of Thyroid Incidentaloma on Liver Transplant: A Study of 1010 Recipients at a Single Center
por: Chan, Yi-Chia, et al.
Publicado: (2022)

Role of autophagy-related protein in the prognosis of combined hepatocellular carcinoma and cholangiocarcinoma after surgical resection
por: Perng, Daw-Shyong, et al.
Publicado: (2021)

Combined Serum ALBUMIN with Neutrophil-to-Lymphocyte Ratio Predicts the Prognosis of Biliary Tract Cancer after Curative Resection
por: Chiu, Tai-Jan, et al.
Publicado: (2023)

Identification of a molecular subtyping system associated with the prognosis of Asian hepatocellular carcinoma patients receiving liver resection
por: Ma, Xiaohua, et al.
Publicado: (2019)

Elevated levels of serum urokinase plasminogen activator predict poor prognosis in hepatocellular carcinoma after resection
por: Tsai, Ming-Chao, et al.
Publicado: (2019)

Elevated Preoperative Serum CA19-9 Levels in Patients with Hepatocellular Carcinoma Is Associated with Poor Prognosis after Resection
por: Chen, Yu-Ling, et al.
Publicado: (2013)

AFP Response to Locoregional Therapy Can Stratify the Risk of Tumor Recurrence in HCC Patients after Living Donor Liver Transplantation
por: Chen, I-Hsuan, et al.
Publicado: (2023)

Metabolic Risks Are Increasing in Non-B Non-C Early-Stage Hepatocellular Carcinoma: A 10-Year Follow-Up Study
por: Lin, Yen-Po, et al.
Publicado: (2022)

The autophagy marker LC3 strongly predicts immediate mortality after surgical resection for hepatocellular carcinoma
por: Lin, Chih-Wen, et al.
Publicado: (2017)

The Role of Protease-Activated Receptor 2 in Hepatocellular Carcinoma after Hepatectomy
por: Tsai, Ming-Chao, et al.
Publicado: (2021)

Less cost by using hanging maneuver and Pringle maneuver in left lateral hepatectomy through small laparotomy wound—experience of Southern Taiwan
por: Lin, Ting-Lung, et al.
Publicado: (2016)

Clinical impact of lenvatinib in patients with unresectable hepatocellular carcinoma who received sorafenib
por: Chen, Yen-Yang, et al.
Publicado: (2020)

The Prognostic Value of Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio in Patients with Hepatocellular Carcinoma Receiving Atezolizumab Plus Bevacizumab
por: Wang, Jing-Houng, et al.
Publicado: (2022)

Hepatocellular Carcinoma associated with Extra-hepatic Primary Malignancy: its Secular change, Clinical Manifestations and Survival
por: Kee, Kwong Ming, et al.
Publicado: (2016)

The impact of esophagogastric varices on the prognosis of patients with hepatocellular carcinoma
por: Hsieh, Wei-Yao, et al.
Publicado: (2017)

Prediction model of hepatocellular carcinoma risk in Asian patients with chronic hepatitis B treated with entecavir
por: Chen, Chien-Hung, et al.
Publicado: (2017)

Stationary Trend in Elevated Serum Alpha-Fetoprotein Level in Hepatocellular Carcinoma Patients
por: Yen, Yi-Hao, et al.
Publicado: (2023)

Short Half-Life of Des-γ-Carboxy Prothrombin Is a Superior Factor for Early Prediction of Outcomes of Hepatocellular Carcinoma Treated with Radiofrequency Ablation
por: Yao, Chih-Chien, et al.
Publicado: (2023)

Comparison of prognosis between surgical resection and transarterial chemoembolization for patients with solitary huge hepatocellular carcinoma
por: Wei, Cheng-Yi, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ji2cvaq0t1sseqok49gl0ru56s